Annual report pursuant to Section 13 and 15(d)

Restricted Cash Equivalents and Investments (Tables)

v3.23.1
Restricted Cash Equivalents and Investments (Tables)
12 Months Ended
Dec. 31, 2022
Restricted Cash Equivalents and Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Securities

December 31, 2022

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

Restricted Cash Equivalents

Short-Term Investments

Long-Term Investments

Restricted cash equivalents:

Money Market funds

$

978,462

$

$

$

978,462

$

978,462

$

$

Subtotal

978,462

978,462

978,462

Investments:

Corporate Notes/Bonds

2,715,607

(48,841)

2,666,766

2,666,766

Subtotal

2,715,607

(48,841)

2,666,766

2,666,766

Total

$

3,694,069

$

$

(48,841)

$

3,645,228

$

978,462

$

2,666,766

$

Schedule of Estimated Fair Value of Available-for-Sale Securities

Amortized Cost

Estimated
Market Value

Due within one year

$

2,715,607

$

2,666,766

Due after one year through five years

$

2,715,607

$

2,666,766